KRISTI SARGENT: Open Payments
NPI 1811642473 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 33 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $231 · 2025 $713
Food & beverage: $614Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $198 |
| ABBVIE INC. | 10 | $169 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ardelyx, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Celltrion USA Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Organon LLC | 1 | $18 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, ENTYVIO, IBSRELA, TERLIVAZ, IQIRVO.
Industry payments across SC — which companies pay providers there.
